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https://doi.org/10.1016/j.molcel.2021.08.024SUMMARYOf the eight distinct polyubiquitin (polyUb) linkages that can be assembled, the roles of K48-linked polyUb
(K48-polyUb) are the most established, with K48-polyUb modified proteins being targeted for degradation.
MINDY1 and MINDY2 are members of the MINDY family of deubiquitinases (DUBs) that have exquisite spec-
ificity for cleaving K48-polyUb, yet we have a poor understanding of their catalytic mechanism. Here, we
analyze the crystal structures of MINDY1 and MINDY2 alone and in complex with monoUb, di-, and penta-
K48-polyUb, identifying 5 distinct Ub binding sites in the catalytic domain that explain how these DUBs sense
both Ub chain length and linkage type to cleave K48-polyUb chains. The activity of MINDY1/2 is inhibited by
the Cys-loop, and we find that substrate interaction relieves autoinhibition to activate these DUBs. We also
find that MINDY1/2 use a non-canonical catalytic triad composed of Cys-His-Thr. Our findings highlight mul-
tiple layers of regulation modulating DUB activity in MINDY1 and MINDY2.INTRODUCTION
Nearly all aspects of eukaryotic cell biology are influenced by the
posttranslational modification (PTM) of proteins with ubiquitin
(Ub). Typically, Ub is tagged onto a substrate protein by the for-
mation of an isopeptide bond between its C-terminal carboxyl
group and the ε-amine group of a lysine residue on the substrate.
This primary Ub can be extended where 1 of its 7 lysine residues
(K6, K11, K27, K29, K33, K48, K63) or its N-terminal methionine
(M1) can serve as an attachment point for another Ub to result in
the formation of polyUb chains (Komander and Rape, 2012).
K48-linked ubiquitylation, the most prevalent linkage type, tar-
gets modified proteins for destruction by the proteasome,
thereby maintaining a functional proteome, the failure of which
is the underlying cause for many diseases, including neurode-
generative disorders (Dikic, 2017; Hershko and Ciechan-
over, 1998).
Given their wide-ranging effects on cell signaling and eukary-
otic biology, ubiquitylation is regulated by dedicated Ub prote-
ases called deubiquitinases (DUBs), which can remove Ub
from the substrate or trim polyUb chains (Clague et al., 2019;
Leznicki and Kulathu, 2017). Of the 100 DUBs known so far in hu-
mans, the majority of them show no linkage preference and can
hydrolyze all polyUb chain types, whereas few DUBs exhibit
exquisite linkage selectivity and cleave only specific linkage
types (Abdul Rehman et al., 2016; Faesen et al., 2011; Kwasna4176 Molecular Cell 81, 4176–4190, October 21, 2021 ª 2021 The Au
This is an open access article under the CC BY license (http://creativeet al., 2018; Mevissen et al., 2013). The mode of Ub recognition
by the DUB determines whether it is linkage specific. For
instance, the USP family DUBs have a large S1 Ub binding site
and their activity depends on distal Ub binding. However,
some DUBs rely on additional proximal Ub interactions at the
S10 site to orient a specific lysine or the N-terminal methionine to-
ward the catalytic site, thus making them selective at cleaving
specific linkages (Clague et al., 2019). A key objective of these
interactions between DUBs and Ub molecules is to stabilize
the linkage between Ub moieties of a chain within the active
site for efficient cleavage, especially since Ub chains of different
linkage types adopt distinct conformations. For instance, M1-,
K33-, and K63-linked chains can exist in an open extended
conformation with accessible I44 binding patches that can be
recognized by DUBs (Kristariyanto et al., 2015; Ronau et al.,
2016). Other linkage types, such as K6-, K11-, and K48-linked
chains, adopt compact conformations and must undergo signif-
icant conformational changes to be recognized by a DUB (Békés
et al., 2016; Gersch et al., 2017; Mevissen et al., 2016; Sato et al.,
2017; Ye et al., 2012). Despite it being themost abundant linkage
type, we do not know how K48-linked polyUb is recognized by
DUBs, as there are no available structures of DUBs bound to
K48-linked chains.
DUBs process Ub chains in diverse ways to modulate ubiqui-
tylation, and the mode of chain cleavage is a factor that can in-
fluence the duration of the Ub signal. For instance, DUBs canthors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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OPEN ACCESSArticlecleave from one end of the chain (exo-DUB) to trim the Ub chain
(Lee et al., 2011; Leznicki and Kulathu, 2017; Wilkinson et al.,
1995). Alternatively, DUBs can hydrolyze linkages at any position
within the Ub chains (endo-DUB) and thereby rapidly terminate a
Ub signal. The endo-cleavage mode is characteristic of DUBs
such as CYLD and A20, which regulate immune signaling
(Komander et al., 2008; Lin et al., 2008). DUBs are also subject
to multiple layers of regulation that ensure activity only at precise
times and locations. Several DUBs exist in an autoinhibited
conformation typified by a misaligned catalytic triad or occluded
substrate-binding site and depend on PTMs, allosteric regula-
tion, or substrate interactions for activation (Sahtoe and
Sixma, 2015).
We recently reported the discovery of the MINDY (MIU con-
taining novel DUB family) enzymes as a separate class of
cysteine protease DUBs. DUBs of the MINDY family are evolu-
tionarily conserved and remarkably specific at cleaving K48-
linked chains (Abdul Rehman et al., 2016). MINDY1 andMINDY2
show high sequence similarity and similar domain architectures.
We found that MINDY1 is an exo-DUB with a preference for
cleaving long K48-linked polyUb chains. Furthermore, MINDY1
exists in an inhibited conformation and the identity of the cata-
lytic triad is unclear. Hence, the catalytic mechanism and how
MINDY1 becomes activated and specifically cleaves K48-linked
Ub chains in this unique fashion are unknown. To address these
questions, we determined here the crystal structures of MINDY1
and MINDY2 in complex with K48-diUb (K48-Ub2) and MINDY2
in complex with K48-pentaUb (K48-Ub5). Our structural ana-
lyses, coupled with mutational studies, reveal the mechanism
of autoinhibition and activation of MINDY1 and MINDY2.
RESULTS
Structure of MINDY1 in complex with K48-linked diUb
The minimal catalytic domains of MINDY1 (MINDY1cat) and
MINDY2 (MINDY2cat) contain all of the specificity determinants
to selectively cleave K48-linked chains (Figures S1A and S1B;
Abdul Rehman et al., 2016). To understand the structural basis
for the specific cleavage of K48-linked chains by MINDY1, we
determined the crystal structures of catalytically dead mutants
of MINDY1cat and MINDY2cat bound to K48-linked diUb, MIND-
Y1C137A:K48-Ub2, andMINDY2
C266A:K48-Ub2, respectively (Fig-
ures 1A and S1D; Table S4). The crystal structures of MINDY2cat
and MINDY1cat closely resemble one another (root-mean-
square deviation [RMSD] 1.05 Å), and both DUBs bind to K48
chains in a similar way (Figure S1C). Overall, we found MINDY1
and MINDY2 to use analogous mechanisms and, to simplify our
description, we focus on MINDY1, highlighting any differences
observed with MINDY2.
The crystal structure of MINDY1C137A:K48-Ub2 complex re-
veals how MINDY1cat has extensive interactions with both the
proximal Ub (Ubprox) and distal Ub (Ubdist) to precisely position
the scissile bond across the catalytic site (Figures 1A and
S1D–S1F). Ubdist binds to the S1 site in MINDY1 with a buried
surface area of only 750 Å2, a binding interface much smaller
than those of other DUBs such as HAUSP/USP7 (1,700 Å2),
USP21 (1,700 Å2), or USP2 (1,900 Å2), which rely more on Ubdist
binding for activity (Hu et al., 2002; Renatus et al., 2006; Ye et al.,2011). In the crystal structure of MINDY1 in complex with prop-
argylated Ub (MINDY1Ub), a covalent complex representing
the product intermediate state, the Ub occupying the S1 site ex-
ists in two alternate conformations suggestive of weak binding.
One of these conformers, conformer A, corresponds to Ubdist
in the K48-Ub2 complex (Figure S2A). This suggests that Ub
prox
interactions with MINDY1cat stabilizes Ubdist binding. Indeed,
Ubprox has a slightly larger binding interface compared to Ubdist
and binds with a buried surface area of 965 Å2.
When bound to MINDY1/2, the K48-linked chain adopts an
extended conformation that lacks interchain Ub-Ub interactions
(Figures 1A and S1D). This contrasts with the compact confor-
mation observed for K48-linked chains in isolation, in which the
I44 patches of both Ubdist and Ubprox form a hydrophobic inter-
face (Figure 1B). In the extended, DUB-bound conformation, the
I44 patches of both Ubprox and Ubdist are now engaged in inter-
actions with the catalytic domain instead (Figure 1A). The I44
patch on Ubdist primarily contacts I266 on MINDY1 (Figure 1C),
and further interactions with Ubdist are mediated by V210,
W240, Y258, and F315, which form a binding pocket for L73 of
Ubdist. Polar interactions between D209 and E263 in MINDY1
with R74 and R72 of Ubdist further contribute to binding (Figures
S2B and S2D). The I44 patch of Ubprox mainly contacts F339 on
MINDY1 (Figure 1D). The binding of Ubprox at the S10 site is
further supported by additional cation-p interactions between
Ubprox F45 and MINDY1 R316, hydrogen bonds between the
side chains of N317 and Ubprox N60 and the backbone of Y59,
and ionic interactions between Ubprox R42 and MINDY1 D336
(Figures S2D–S2F).
Disruption of the binding of Ubdist or Ubprox in the MINDY1
mutants I266A (S1 site) and F339A (S10 site), respectively, re-
sults in reduced activity relative to wild type (WT), as monitored
by the cleavage of fluorescently labeled K48-Ub5 (Figures 1E
and S1G). As the double mutant (I266A/F339A) completely
abolishes DUB activity (Figures 1E and 1F) and residues
involved in Ubprox and Ubdist recognition are evolutionarily
conserved (Figures S2B and S2C), we conclude that simulta-
neous engagement of the I44 patches of both Ubprox and Ubdist
is essential to properly position the scissile bond for MINDY1
and MINDY2 to cleave K48 chains. Comparison of all of the
available structures of DUBs in complex with diUb chains re-
veals that this mode of symmetric binding, where the I44
patches of both Ubprox and Ubdist are engaged with the DUB,
is unique to MINDY1/2 (Figure 1A, inset; Table S1). K48-linked
chains exist in a dynamic equilibrium between closed and open
conformations (Ye et al., 2012); however, the extended confor-
mation adopted by K48-linked diUb, when bound to the cata-
lytic domains of MINDY1 and MINDY2, is distinct from all
previously reported conformations of K48-linked chains (Fig-
ures S2G and S2H). To our knowledge, these structures of
MINDY1/2 represent the first crystal structures of any DUB in
complex with K48-linked Ub chains.
Cys loop regulates DUB activity
InMINDY1 andMINDY2, a flexible loop (T130 to P138 inMINDY1
and T259 to P267 in MINDY2) connects b2 to a1, which we term
the Cys loop since the catalytic cysteine sits at its base. In the
apo-form of the DUB, this Cys loop occludes the catalytic centerMolecular Cell 81, 4176–4190, October 21, 2021 4177
Figure 1. Crystal structures of MINDY1 in complex with K48-linked di-ubiquitin
(A) TheMINDY1C137A:K48-Ub2 complex crystal structure is shownwithMINDY1 in illustration (light pink). Ubmolecules are depictedwith transparent surfaces (tv-
orange:Ubprox and yelloworange:Ubdist). I44 patches on Ub are colored blue, and an alternate view of the bound diUb rotated by 220 along the x axis is shown on
the right side. Schematic representation of MINDY1C137A:K48-Ub2 complex (inset).
(B) Surface representation of the closed conformation of K48-Ub2 (PDB: 1AAR) with I44 patches highlighted in blue.
(C and D) Close-up views of the key residues on the MINDY1 S1 and S10 sites and their interactions with the I44 patches on Ubdist and Ubprox.
(E) DUB assay monitoring cleavage of K48-linked pentaUb, in which Ubprox is fluorescently labeled by MINDY1 and indicated mutants.
(F)QuantificationofpentaUbhydrolysis shown in (D). Thepercentageof the total intensitiesofUb4,Ub3,Ub2,andUb1 formed is shownon they axis. n=2;mean±SD.
See also Figures S1 and S2.
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OPEN ACCESS Articleand would sterically hinder positioning of the scissile bond
across the active site (Figure 2A). Comparing the structures of
the MINDY1C137A:K48-Ub2 complex with MINDY1
apo does not
show any large-scale conformational changes induced within
the catalytic domain upon Ub binding (RMSD 1 Å over 2444178 Molecular Cell 81, 4176–4190, October 21, 2021aligned Ca atoms) (Figure S3A). The only significant change is
in the Cys loop that undergoes significant remodeling, during
which several hydrogen bonds are broken, accompanied by
the formation of new bonds (Figures 2B and S3B–S3D). This
extensive interaction network and remodeling of the Cys loop
Figure 2. Cys loop mobility regulates DUB activity
(A) Representation of the Cys loop in a superposition ofMINDY1apo (cyan) andMINDY1C137A:K48-Ub2 complex (pink). The isopeptide bond betweenK48 of Ub
prox
(orange) and G76 of Ubdist (yellow) is shown in sticks.
(B) Close-up view of (A) showing amino acid side chain rearrangements (side view).
(C) Surface representation of the hydrophobic pocket in MINDY1apo that accommodates the Cys loop residue P138.
(D) Coomassie-stained gel comparing activity of MINDY1 WT and P138A to UbPrg in a time course.
(E) Steady-state kinetics of K48-linked pentaUb cleavage by MINDY1WT and P138A mutant derived from reactions with varying concentrations of fluorescently
labeled Ub5 (n = 2; means ± SDs).
(F) Silver-stained gel comparing cleavage of K48-Ub3 by MINDY1 WT and indicated mutants.
(G) DUB assay comparing cleavage of K48-Ub2 by MINDY1 WT and P138A mutants.
(H) DUB assay monitoring cleavage of diUb of 7 different linkage types by MINDY1 P138A.
See also Figure S3.
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OPEN ACCESSArticleis also observed inMINDY2 (Figures S3E and S3F), and when re-
structured, the Cys loop no longer impedes Ub binding. In the
apo structure, in addition to the obstructing Cys loop, the cata-
lytic residues are misaligned in an unproductive conformation(Abdul Rehman et al., 2016). Hence, the apo state of the enzyme
corresponds to an inactive, autoinhibited conformation and the
DUB transitions to an active state, when in complex with K48-
linked diUb.Molecular Cell 81, 4176–4190, October 21, 2021 4179
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flanked by proline residues: MINDY1 (P136-C137-P138) and
MINDY2 (P265-C266-P267). When we compare Cys loop con-
formations in the autoinhibited and active states of MINDY1,
P138 in the Cys loop remains fixed, while the rest of the loop
moves (Figure 2B). P138 sits in a hydrophobic pocket formed
by A141, I142, L204, L208, F229, and F320 to function as an an-
chor point for the Cys loop (Figures 2C and S3C). When in com-
plex with diUb, the nature of the interactions of P138 within the
hydrophobic pocket change, with only L204, L208, and F320
mediating interactions, whereas F229 and I142 now no longer
interact with P138 (Figure S3D). In contrast to the anchored
P138, the other flanking proline, P136, shows significant move-
ment upon complex formation (Figure 2B). P136 does not
interact with neighboring residues in the apo state; however, in
the diUb-bound active state, P136 is part of a strong intramolec-
ular interaction network consisting of hydrophobic interactions
with Y114, L139, L140, and A205 (Figures S3C and S3D).
Based on these observations, we predict that P138modulates
the dynamics of the Cys loop, as it provides rigidity to the loop by
anchoring itself into the hydrophobic pocket. Hence, the muta-
tion of P138 to alanine should dislodge the hydrophobic pocket
interactions and result in a more dynamic, flexible loop. To test
this possibility, we determined the crystal structures of the
MINDY1 P138A mutant on its own and in complex with K48-
Ub2. As hypothesized, the absence of P138 results in a less-
extensive engagement with the hydrophobic pocket, resulting
in a more mobile Cys loop, as suggested by higher b-factors of
its residues (Figures S3G–S3K). To determine the effect of a
more flexible Cys loop on DUB activity, we assayed the reactivity
of MINDY1 toward UbPrg. In contrast to the WT enzyme, the
P138Amutant was readily modified byUbPrg, thereby supporting
our notion that the P138A mutation makes the Cys loop more
flexible to reduce the steric hinderance to Ub binding (Figure 2D).
Next, we determined enzyme kinetics using fluorescently labeled
K48-linked pentaUb, which revealed thatMINDY1 P138Amutant
is a much more active enzyme with >10-fold higher kcat and 3-
fold lower Km compared to MINDY1 WT (Figure 2E). As the Cys
loop sterically interferes with polyUb binding, an increase in loop
flexibility may account for the observed reduction in Km.
To test the role of the hydrophobic pocket in keeping P138
anchored, we mutated P138 to smaller residues (A or G), which
would disrupt anchoring, or to bulky hydrophobic residues (L or
W), which would lock the Cys loop in the inhibited state. A chain
cleavage assay with these mutants shows that disrupted
anchoring (P138A or P138G) increases chain cleavage, whereas
increased hydrophobicity of the side chain impairs DUB activity
(Figure 2F). The consequence of a more flexible loop is also un-
derscored by the ability of MINDY1 P138A to cleave diUb, which
MINDY1 WT is unable to cleave (Figure 2G). Similarly, mutating
the equivalent residue in MINDY2 (P267A) also leads to
increased DUB activity (Figures S3L and S3M). Fittingly, Miy2
(Ypl191C), the yeast ortholog of MINDY2, has an alanine at this
position (A29), which may explain why Miy2 is a much more
active enzyme compared to MINDY1 (Abdul Rehman et al.,
2016). Importantly, increasing Cys loop flexibility and thereby
catalytic activity with the P138A mutation does not change the
linkage specificity of MINDY1 for K48 chains, as the mutant4180 Molecular Cell 81, 4176–4190, October 21, 2021only cleaves K48 chains and no other linkage type (Figure 2H).
Collectively, these results demonstrate that the Cys loop regu-
lates MINDY1 catalytic activity, but not linkage selectivity.
Mechanism of autoinhibition
Mutation of the other Cys-flanking proline P136, MINDY1 P136A,
is unable to cleave diUb, whereas the P138A mutant is very
active (Figures 2G and 3A). However, the double-mutant
MINDY1 P136A/P138A shows diminished activity compared to
the P138A mutant, suggesting a regulatory role for P136. One
notable intramolecular interaction of P136 is with the phenyl
ring of Y114 (Figure S3D). In the autoinhibited state of MINDY1,
sulfur-centered hydrogen bonding of the catalytic C137 with the
hydroxyl of Y114 rotates C137 away from the active site (Fig-
ure 3B). In the active conformation, this inhibitory Y114-C137
interaction is broken due to the Cys loop movement, and the
side chain of Y114 now hydrogen bonds with S163 (Figures 3C
and 3D). Interestingly, in theMINDY1Ub complex, which repre-
sents the product-bound intermediate state, Y114 is hydrogen
bonded to S163 before the transition back from the activated
to the inhibited state after Ub chain hydrolysis (Figure S4A).
These observations strongly imply a linchpin role for Y114 in
regulating the transition from an inhibited to active state. Disrup-
tion of this single hydrogen bondwith a Y114Fmutation results in
increased DUB activity, with an 30-fold increase in kcat
compared to WT (Figures 2E and 3E–3H). A conserved mecha-
nism operates in MINDY2, as mutation of the analogous residue
Y243 also leads to increased DUB activity (Figures S4B and
S4C). Y114 is surrounded by hydrophobic residues, which
interact and stabilize the position of the phenyl ring, and in
fact, the MINDY1 Y114A mutant is less active compared to WT
and the Y114F mutant (Figures 3G, 3H, and S4D).
In addition to P138 and Y114, the inhibitory conformation of
the Cys loop is further maintained by the intramolecular interac-
tion between N134 and S132 in MINDY1 (Figure S3B). When in
complexwith K48-Ub2, this interaction is broken asN134 now in-
teracts with K48, G76, and E51 of Ubprox (Figure 3I). These inter-
actions of the side chain of N134with the substrate are important
for deubiquitylation activity, as mutating N134 to alanine impairs
the catalytic activity of MINDY1 (Figure 3J). This suggests a
model of substrate-assisted catalysis, where interaction of
S132 and N134 of MINDY1 with residues in Ub enable the tran-
sition of MINDY1 from an inhibited to an active enzyme.
In the autoinhibited state of MINDY1, the oxyanion hole form-
ing Q131 is hydrogen bonded to the catalytic H319 (Figure S4E).
In the active state observed in the MINDY1C137A: K48-Ub2 com-
plex, N134 and the catalytic H319 both form hydrogen bonds
with K48 (Figure 3I) and Q131 interacts with the isopeptide
bond (Figure S4F). In addition to the interactions with Ubprox
that stabilize the catalytic site in a productive conformation,
Ubprox also stabilizes the binding of Ubdist onto the S1 site (Fig-
ure S2A). Hence, in a substrate-activated mechanism, the bind-
ing of K48-linked polyUb stabilizes the productive conformation
of the catalytic site in MINDY1 and MINDY2. In the absence of
Ubprox in the MINDY1Ub structure, both H319 and Q131 exist
in two alternate conformations. In one conformation, H319 is
hydrogen bonded to Q131, similar to the inhibited state; howev-
er, in a second conformation, Q131 is flipped out and does not
Figure 3. Autoinhibition and activation of MINDY1
(A) DUB assay monitoring the cleavage of K48-Ub2 by MINDY1 and indicated mutants.
(B) Close-up view of catalytic residues and their interactions inMINDY1 (apo). C137 is out of plane with H139 and is hydrogen bonded with Y114 inMINDY1 (apo).
Red dotted lines indicate hydrogen bonds.
(C) Close-up view as in (B) for theMINDY1C137A:K48-Ub2 complex. The catalytically productive state conformation leads to the formation of new sets of bonds as
shown. The oxyanion hole residue Q131, which was in contact with catalytic H319 in (B), now forms interactions with the carbonyl of the incoming scissile bond.
(D) Lateral movement of Y114 and its interactions in MINDY1 (apo) and MINDY1C137A:K48-Ub2 complex.
(E) DUB assays comparing cleavage of fluorescently labeled pentaUb by MINDY1 and Y114F mutant. The percentage hydrolysis of pentaUb is plotted against
time (right).
(F) Steady-state kinetics of K48-linked pentaUb cleavage by MINDY1 Y114F (n = 2; means ± SDs).
(G) Close-up view of Y114 (phenyl ring) interactions with hydrophobic residues on adjoining secondary structure elements in MINDY1 (apo).
(legend continued on next page)
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OPEN ACCESS Articleinteract with any neighboring residue (Figure S4G). In contrast, in
MINDY2apo, the catalytic H448 is flipped out, and Q260 is not
able to form a hydrogen bond (Figures S4H and S4I). However,
the binding of Ubprox brings H448 closer to the catalytic C266
to form a productive active site (Figure S4J). In summary, the
Cys loop dynamics and the interactions with K48-linked chains
modulate the transition of MINDY1 and MINDY2 from an in-
hibited to an active state.
Non-canonical catalytic mechanism
In most thiol proteases, a third catalytic residue, usually an Asp
or Asn, serves to correctly position the catalytic His (Clague
et al., 2019). In all of the determined structures of MINDY1 and
MINDY2, the identity of this third catalytic residue is unclear. In
the MINDY1C137A:K48-Ub2 structure, S321 is 3.6 Å away from
H319 and could function as a catalytic residue, as described
for USP30 (Figure 4A; Gersch et al., 2017; Sato et al., 2017).
However, to our surprise, MINDY1 S321A mutation did not
abolish activity, but instead resulted in a modest increase in
MINDY1 activity (Figure 4B). A search for other potential residues
only revealed a distant T335 situated 6 Å away (Figure 4A).
Despite this distance, we found a water molecule to coordinate
T335 with H319 via hydrogen bonding, an unusual mechanism
that may serve to orient H319 for catalysis, thereby adopting
the function of the third catalytic residue (Figures 4C and S5A).
To test whether such an unusual catalytic architecture is
possible, we introduced a T335V mutation to disrupt this water
bridge, which resulted in a substantial loss of activity (Figure 4D).
We conclude that T335 competes with S321 to correctly position
H319 for catalysis, thus adding another layer of regulation. In this
scenario, S321 functions as an inhibitory residue, explaining why
the S321A mutation enhances activity. Further supporting this
model is the mutation of S321 to aspartate, which completely
abolishes the catalytic activity, as a strong ionic bond between
S321D and the catalytic histidine (H319) likely blocks the
catalytic function of H319, thus rendering the DUB inactive
(Figure 4B).
AsT335serves a catalytic function tocorrectly positionH319 for
catalysis, we wondered if mutating T335 to a negatively charged
residue would enhance the activity of MINDY1. To our surprise,
the mutation of T335 to aspartate also abolishes MINDY1 activity
(Figure 4D). To understand the reason underlying this loss of activ-
ity, we determined the crystal structure ofMINDY1T335D, which re-
vealed the formationofan ionic interactionbetweenT335Dand the
catalyticH319.H319 is locked in thisconformation,which is further
rigidified by the network of hydrogen bonds with Q131, S321, and
N134, resulting in the catalytic Cys being rotated away from H319
(Figures 4E and S5B). Hence, the mutation T335D also forces the
enzyme into an unproductive catalytic state, thus highlighting the
requirement of a water molecule to bridge an interaction with
T335 via hydrogen bonding to correctly position H319. MINDY2
also uses a similar non-canonical catalytic architecture in which(H) A close-up image of active site of apo MINDY1 Y114F mutant compared to W
(I) Interactions of Cys loop residue N134 in stabilizing the isopeptide bond for ca
(J) Cleavage of pentaUb chains fluorescently labeled on Ubprox by MINDY1 WT a
assay. n = 2; mean ± SD.
See also Figure S4.
4182 Molecular Cell 81, 4176–4190, October 21, 2021T464 is the thirdcatalytic residueandS450servesasacompetitive
element (Figures S5C–S5E).
Why does MINDY1 preferentially cleave long Ub chains?
The minimal catalytic domains of both MINDY1 and MINDY2
show higher activity at cleaving longer chains as revealed by
DUB assays with fluorescently labeled polyUb chains of
increasing length (Figures S6A and S6B). We hypothesize that
the preference of these DUBs for cleaving longer chains is due
to the presence of additional Ub binding sites within the catalytic
domain. If MINDY1 and MINDY2 do have additional Ub binding
sites, we predict that they would have higher affinity for longer
K48 chains compared to K48-Ub2. Hence, we performed
isothermal calorimetry (ITC) measurements in which catalytically
dead MINDY1 C137A was titrated into K48-diUb, triUb, tetraUb,
or pentaUb (Figure S6C). While there was nomeasurable binding
for diUb by ITC, we observed an increase in binding affinity with
increasing chain length. MINDY1 binds to triUb with an affinity of
6 ± 3 mM, which increases to 1 ± 0.2 mM for tetraUb and to
250 nM for pentaUb. To determine whether MINDY1 is specific
not only at cleaving K48-linked chains but also at recognizing
them, we tested whether K29- and K33-tetraUb, chains not
cleaved by MINDY1, could bind to it. These ITC measurements
revealed thatMINDY1C137A does not bind K29- and K33-linked
chains (Figure S6D). These results indicate that the arrangement
of the Ub binding sites on the enzyme permit only K48-linked
chains to bind, and MINDY1/2 has at least five distinct Ub bind-
ing sites within its catalytic domain.
To conclusively establish whether the catalytic domain con-
tains five Ub binding sites, we crystallized the catalytic domain
of MINDY2 in complex with K48-Ub5. The structure of the com-
plex reveals 5 Ub molecules wrapped around the catalytic
domain of MINDY2, resembling a pearl necklace (Figures 5A
and 5B; Table S4). All Ub binding sites show high conservation
among metazoa, with the S1 and S10 sites being particularly
highly conserved (Figures 5D and S6E). A closer look at how
Ubs bind to the S20-S30 sites reveals that they are primarily
centered around the I44 patch of Ub. Interaction with Ub at the
S20 site is mediated via V242 and I289 of MINDY2 (Figure 5E).
At the S30 site, L304 engages with the Il44 patch of Ub and
both S324 and D325 interact with R42 via hydrogen bonding
and ionic bonding, respectively (Figure 5G). In contrast to the
other sites, Ub binding at the S40 site does not involve the I44
patch and is instead primarily mediated by hydrogen bonding
between E350 of MINDY2 and the backbone of D52 of Ub, ionic
interactions of R342 with D52 of Ub and cation-p stacking be-
tween Y351 and R72 of Ub (Figure 5I). Mutating key residues
at each site on MINDY2 to weaken the interaction with Ub im-
pedes the ability of MINDY2 to cleave pentaUb (Figures 5F,
5H, 5J, and 5K). Furthermore, mutating residues at equivalent
positions in MINDY1 also inhibit cleavage of Ub5 (Figures S6F
and S6G). These experiments highlight the importance of UbT. Hydrogen bonding of C137 to Y114 is broken in the mutant.
talysis.
nd N134A mutant. The panel on the right shows the quantification of the DUB
Figure 4. MINDY1 uses a non-canonical catalytic mechanism
(A) Close-up view of the catalytic site in MINDY1 apo. The dotted red lines indicate hydrogen bonds, the dotted black line the ionic bond, and the blue sphere
indicates water molecule.
(B) DUB assay comparing the cleavage of fluorescently labeled K48-Ub5 by MINDY1 WT, S321A, and S321D mutants. The percentage of pentaUb hydrolyzed is
plotted against time (right). n = 2; mean ± SD.
(C) Close-up view of the catalytic site in MINDY1C137A:K48-Ub2 complex.
(D) DUB assay as in (B) comparing the chain cleavage byMINDY1WT, T335V, and T335Dmutants. The percentage of pentaUb hydrolyzed is plotted against time
(right). n = 2; mean ± SD.
(E) Close-up view of the catalytic site in MINDY1T335D.
See also Figure S5.
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MINDY2cat for efficient cleavage of K48-polyUb.
To validate the presence of 5 distinct Ub binding sites on
MINDY2, we performed small-angle X-ray scattering (SAXS) an-
alyses on different MINDY2 complexes. SAXS data were
collected for MINDY2 on its own, covalently linked to UbPrg
and in complex with K48-Ub2, Ub3, Ub4, and Ub5 (Figure S7A;
Table S2). The SAXS curves were first computed from all of the
working models by using CRYSOL (Svergun et al., 1995) and
compared with the experimental data. For both MINDY2 apo
and MINDY2Ub complex, computed data from the models
yielded good agreement with the experiment, confirming the
two structures in solution (Figures 5L and S7A; Table S2). Forcomplexes with Ub chains, some deviations were observed (Fig-
ures 5L and S7B–S7E), and the expected models were further
refined to fit the SAXS data. The SAXS data of the MINDY2-
C266A:K48-Ub2 complex were analyzed for the presence of com-
plexes with distinguishable Ub2 binding positions with OLIG-
OMER (Konarev et al., 2003). The best fit was obtained for a
mixture of two different binding modes: productive (15%),
where Ub moieties are bound in the S1 and S10 sites, and unpro-
ductive (85%), where they are bound in the S1 and S30 sites
(Figures 5L and S7B). Interestingly, this unproductive mode re-
sembles the K48-Ub2 conformation recognized by OTUB1
(Juang et al., 2012; Wiener et al., 2012; Figure S2H). The higher
prevalence of Ub binding in the unproductive mode possiblyMolecular Cell 81, 4176–4190, October 21, 2021 4183
(legend on next page)
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MINDY2. Importantly, the SAXS data for the MINDY2-
C266A:K48-Ub5 complex are in good agreement with the obtained
crystal structure, with a c2 value of 1.48 (Figure 5L), validating
that the conformations observed in the crystal structure and in
solution are similar (Figure S7E). In summary, the enzyme as-
says, ITC measurements, SAXS analyses, and crystal structures
convincingly show that five distinct Ub binding sites are present
within the minimal catalytic domain.
Ubiquitin chain length determines exo- or endo-
cleavage
Wehadpreviously demonstrated thatMINDY1 is an exo-DUB that
cleaves pentaUb from the distal end of the chain to release oneUb
moiety at a time from the end of the chain (Abdul Rehman et al.,
2016). One mechanism to achieve such directionality of cleavage
would be that MINDY1 recognizes the distal end of the chain.
However, close examination of the MINDY2C266A:K48-Ub5 struc-
ture revealed that the K48 residue of Ubdist is solvent exposed,
which implies that this Ub does not necessarily have to be the
extreme distal moiety in a chain (Figure S8A). MINDY1/2 could
therefore, in principle, possess endo-activity and cleave within a
Ubchain. Aswehere identified fiveUbbinding siteswithin the cat-
alytic domain, we carefully analyzed howMINDY1/2would cleave
chains containing more than five Ub moieties.
When long K48-linked chains containing more than five Ub
moieties were incubated with MINDY1/2, these long chains
collapsed to predominantly form a mixture of chains contain-
ing up to four Ub molecules (Figures 6A and 6B). Compared to
the long chains of five or more Ubs, tetraUb is not a preferred
substrate and rapidly accumulates initially, which is further
processed by gradual cleavage only at later time points. To
confirm our observation that MINDY1/2 may not be exo-
DUBs when presented with long Ub chains, we generated
longer K48-linked polyUb chains (>7 Ub), each labeled with
a fluorophore only at the extreme distal Ub moiety. If MINDY
is a strict exo-DUB, it would cleave these chains from the
distal end to yield only fluorescent monoUb as the main prod-
uct at early time points, and no other fluorescent speciesFigure 5. Crystal structure of MINDY2 in complex with K48-linked pen
(A) The MINDY2C266A:K48-Ub5 complex crystal structure with MINDY2 (light blue
tv-orange, S20: bright orange, S30 light orange, S40: wheat).
(B) Schematic representation of MINDY2C266A:K48-Ub5 complex with Ile44 patc
(C) Surface representation of MINDY2, with the footprint of each Ub highlighted
(D) Surface conservation analysis of MINDY2 from metazoan ortholog sequenc
the surface residues are colored by conservation score. The pentaUb chain i
are annotated.
(E) Close-up of key residues at the S20 site and their interactions with Ub.
(F) DUB assay comparing cleavage of K48-Ub5 by MINDY2 WT and the indicate
(G) Close-up of key residues at the S30 site and their interactions with Ub.
(H) DUB assay comparing cleavage of K48-Ub5 by MINDY2 WT and indicated S
(I) Close-up of key residues at the S40 site and their interactions with Ub.
(J) DUB assay comparing cleavage of K48-Ub5 by MINDY2 WT and indicated
this study.
(K) DUB assay comparing cleavage of fluorescently labeled K48-Ub5 by MINDY
(L) SAXS curves of MINDY2, apo molecule, and in complex with monoUb, K48-lin
models by CRYSOL. For Mindy2-Ub3, normal mode analysis (NMA) with SREFLEX
OLIGOMER was applied on atomic models in which Ub2 occupying positions S1
See also Figures S6 and S7.(Ub2–Ub6) should be formed. However, we observe that
both MINDY1 and MINDY2 rapidly produce a range of fluores-
cent cleavage products that lie between Ub1 and Ub7, sug-
gesting endo-activity as the DUB can cleave anywhere within
the polyUb chain, resulting in the formation of chains of all in-
termediate lengths as products (Figures 6C and 6D). These re-
sults suggest that MINDY1/2 can work as endo-DUBs to
cleave within long chains (>5 Ub), but act as exo-DUBs on
shorter chains (<6 Ub) to cleave the distal Ub. Hence, in addi-
tion to being specific for K48-linked polyUb, MINDY1 and
MINDY2 also sense Ub chain length to position and cleave
long K48-linked chains down to tetraUb.
DISCUSSION
The three crystal structures ofMINDY1 reveal distinct states in the
catalytic cycle ofMINDY1, namely, autoinhibited (Apo), substrate-
bound active state (MINDY1C137A:K48-Ub2) and the product-
bound intermediate state (MINDY1Ub) (Figures 7 and S8B). In
the apo state, the Cys loop mediates autoinhibition and sterically
interferes with Ub binding. While large-scale conformational
changes are not observed upon enzyme:substrate complex for-
mation, Ubbinding at the S10 site releases the autoinhibitionmedi-
ated by the Cys loop to stabilize Ub binding at the S1 site. Hence,
in a model of substrate-driven activation, Ub bound at the S10 site
interacts with the Cys loop to drive the transition of MINDY1 and
MINDY2 from inhibited to active enzymes.
In MINDY1 and MINDY2, the correct positioning of the scis-
sile bond requires Ub binding at both the S1 and S10 sites. In
several DUBs, polyUb recognition and cleavage depends on
extensive Ub interactions at the S1 site (Leznicki and Kulathu,
2017). When binding at the S1 site is not strong, DUBs rely on
additional interactions commonly at the S10 site or S2 sites
(Békés et al., 2015; Flierman et al., 2016; Ye et al., 2011). This
is a hallmark of DUBs such as CYLD and OTU family DUBs,
where Ub interactions at the S10 site place the proximal Ub in
a position that orients a specific lysine into the catalytic site,
thereby conferring linkage specificity (Licchesi et al., 2011; Me-
vissen et al., 2016; Sato et al., 2015). A similar mechanismtaUb
). Ub molecules are depicted with transparent surfaces (S1: yellow orange, S10:
hes on Ub involved in binding shown in blue.
at each Ub-binding site.
es. MINDY2 is shown as a surface model, rotated by 90 in each view, and
s shown as a yellow ribbon model, and the 5 Ub binding sites on MINDY2
d S20 site mutants.
30 site mutants.
S40 site mutants. Dashed line: gel truncation to exclude mutants irrelevant to
2 WT and S20, S30, and S40 mutants. n = 3; mean ± SEM.
ked Ub2, Ub3, Ub4, and Ub5, respectively, and their fits computed from atomic
was used for the refinement of the expected atomic models. For Mindy2-Ub2,
and S10 or S1 and S30 were used to quantify their mixture.
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Figure 6. Ubiquitin chain length determines exo- and endo-cleavage activities
(A) Silver-stained gels of DUB assays monitoring cleavage of long K48-linked polyUb chains containing >6 Ub moieties by MINDY1FL and MINDY1cat.
(B) As in (A), but comparing MINDY2FL and MINDY2cat.
(C) DUB assay monitoring cleavage of distally labeled longer polyUb chains by MINDY1FL and MINDY1cat with 2 known endo-DUB controls: MIY2 and OTUB1.
(D) As in (D), but comparing MINDY2FL and MINDY2cat.
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OPEN ACCESS Articledrives linkage selectivity in MINDY1 and MINDY2, where the
proximal Ub is positioned in such a way that only K48-linked
polyUb can access the catalytic groove. Our SAXS data show
that a significant proportion of diUb binds the DUB in a non-pro-
ductive conformation at the S1 and S30 sites, which suggests
another regulatory layer to select for long polyUb chains that
can simultaneously engage with all Ub binding sites on the
DUB and properly position the scissile bond for cleavage.
MINDY1 has a weak affinity for K48-linked diUb and the steric
hindrance imposed by the Cys loop prevents diUb binding
and therefore cleavage. The P138A mutation, which increases
the mobility of the Cys loop not only enables transition to the
active conformation but also facilitates Ub binding as evi-
denced by lower Km for pentaUb and binding to diUb.
PolyUb chains, including K48-linked chains, have been
observed in different conformations and are dynamic in solution,
existing in an ever-changing equilibrium between closed and
open conformations (Cook et al., 1992; Eddins et al., 2007; Hir-
ano et al., 2011; Lai et al., 2012; Lu et al., 2020; Trempe et al.,
2010; Ye et al., 2012). Our structures reveal that the K48 chains
adopt an extended conformation when positioned across the
active site of MINDY1/2. Furthermore, we observed pentaUb
wrapping around MINDY2 like a pearl necklace, in an open
conformation where the I44 patches of all Ub moieties, except
the most proximal Ubs, engage with the DUB for binding. Of
note, our data suggest that K48-linkage specificity is also main-
tained at the proximal end, as other chain types tested do not
bind to MINDY1. Despite the range of conformations that can
be adopted by Ub chains, it is remarkable how enzymes and4186 Molecular Cell 81, 4176–4190, October 21, 2021binding domains have evolvedmechanisms to selectively recog-
nize polyUb of a particular linkage type and length.
The most favorable polyUb binding mode that results in the
most efficient cleavage is that all Ub-binding sites on the DUB
are occupied. Therefore, MINDY1/2 can efficiently bind a K48-
Ub chain of length n (with n R 5) in n-4 preferred ways within
the chain, resulting in a rapid collapse of longer chains to tet-
raUb. Starting with pentaUb, the minimum chain length that
can satisfy the binding requirements, an exo-form of cleavage,
is forced, with one Ub monomer being trimmed from the chain
with each cleavage event. As the chains become shorter
(<5 Ub), all five binding sites can no longer be occupied, thus
leading to a decrease in cleavage efficiency. TetraUb, for
instance, does not occupy all of the binding sites on the DUB,
and consequently cleavage is inefficient, resulting in the
observed accumulation of Ub4 (Figures 6A–6D). We therefore
propose that MINDY1 and MINDY2 primarily act as endo-
DUBs to rapidly recognize and trim long Ub chains down to tet-
raUb. An emerging theme in ubiquitylation is a role for the length
of the polyUb chain in determining the consequence of the post-
translational modification. For instance, the protease DDI2 will
cleave the transcription factor NRF1 only when it is modified
with long polyUb chains (Dirac-Svejstrup et al., 2020). Similarly,
the unfoldase Cdc48/p97-Ufd1-Npl4 has several Ub binding
sites and efficiently unfolds Mcm7 only when it is modified with
K48 chains containing at least five Ubs (Deegan et al., 2020;
Twomey et al., 2019).
Our studies of MINDY1 and MINDY2 reveal two remarkably
similar enzymes, with analogous regulatory mechanisms and
Figure 7. Model summarizing the catalytic
mechanism of K48-linked polyUb
(A) MINDY1 and MINDY2 exist in an autoinhibited
conformation in which the Cys loop is in a closed
conformation that sterically interferes with Ub
binding and also contributes to keeping the catalytic
site inhibited.
(B) In a substrate-driven mechanism, Ub in-
teractions release inhibition and activate the DUB,
resulting in chain cleavage and release of the Ub
chain.
(C) In the product intermediate transitional tetrahe-
dral state, the Ub occupies the S1 site. As this is not
a strong binding interface, this Ub exists in 2
different conformers.
Attack by a water molecule releases the Ub and
returns the DUB to an inhibited conformation.
Created using Illustrate (Goodsell et al., 2019).
See also Figure S8.
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modular DUBs that, in addition to their catalytic domain, possess
N-terminal regions of unknown function and distinct C-terminal
tandem MIU domains (tMIU) (Abdul Rehman et al., 2016), and
potential differences in the biological roles of MINDY1 and 2
are likely to arise from these additional domains. The tMIU of
MINDY1 is highly selective at binding to K48-linked polyUb
chains, with MIU2 of the tandem motif being the main determi-
nant of this specificity (Kristariyanto et al., 2017). In contrast,
the tMIU of MINDY2 is non-specific and binds to polyUb chains
of different linkage types. This raises the possibility that MINDY2
cleaves polyUb containing mixed or branched Ub linkages,
where the tMIU binds to the non-K48-linked part of the chain
and the DUB cleaves the K48 linkages, suggestive of a cellular
function distinct from MINDY1.
Crystal structures of many DUBs reveal that their catalytic res-
idues are often in unproductive conformations in the absence of
substrate, and conformational rearrangements are triggered by
Ub binding, leading to realignment of the catalytic residues into
a productive conformation (Boudreaux et al., 2010; Hu et al.,
2002; Keusekotten et al., 2013; Mevissen et al., 2016; Sato
et al., 2015). Similarly, we observed Ub binding to MINDY1/2
to induce several structural rearrangements leading to a func-
tional active site. Most thiol DUBs feature the canonical catalytic
triad composed of Cys, His, and Asp/Asn (Ronau et al., 2016).
The Asp/Asn residue plays a secondary role by properly orient-
ing the His in the catalytic triad. DUBs such as USP16, USP30,
and USP45 have a serine in place of the Asp/Asn, makingMolecularthem distinct from other DUBs (Gersch
et al., 2017; Sato et al., 2017). MINDY1 fea-
tures an atypical catalytic triad in which a
Thr residue orients the His via a water
bridge. Intriguingly, a local non-catalytic
Ser residue plays an inhibitory role by
competing with the catalytic Thr for inter-
action with the catalytic His and improperly
orienting it. This is reminiscent of OTULIN,
in which inhibitory interactions mediatedby an Asp with the catalytic His inhibit the DUB and are relieved
upon substrate binding (Keusekotten et al., 2013). In MINDY1
and MINDY2, an additional layer of regulation is imparted by a
sulfur-centered hydrogen bond between a Tyr and the catalytic
Cys, which further reinforces autoinhibition.
In summary, our work reveals that MINDY1 and MINDY2 are
specialized DUBs that sense both Ub chain length and linkage
type. The remarkable specificity that MINDY1 and MINDY2
possess at cleaving K48-linked chains to trim long polyUb chains
may help reveal the cellular functions of these evolutionarily
conserved DUBs. That MINDY1 and MINDY2 have evolved so
many layers of regulation and activation steps suggests key reg-
ulatory functions for these DUBs.
Limitations of the study
Our work reveals the mechanisms of autoinhibition and activa-
tion in MINDY1 and MINDY2 and the recognition of long Ub
chains as preferred substrates. It is intriguing that MINDY1 and
MINDY2 possess such remarkable chain-trimming activity; how-
ever, without insights into the identity of the substrates of these
enzymes, it is difficult to establish the significance of the activity
of MINDY1/2 in pruning polyUb down to tetraUb. While we show
the presence of five distinct Ub binding sites on the catalytic
domain of MINDY, our analyses do not reveal whether there is
a specific order in which the Ub moieties within the chain bind.
Despite these limitations, our work reveals fundamental insights
into the mechanism of MINDY1 and MINDY2. Furthermore, our
characterization will allow these enzymes to be used as valuableCell 81, 4176–4190, October 21, 2021 4187
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OPEN ACCESS Articletools to study Ub signaling, especially to probe the role of Ub
chain length in eliciting cellular responses.
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B., Hung, L., Jain, S., McCoy, A., et al. (2019). Macromolecular structure
determination using X-rays, neutrons and electrons: recent developments
in Phenix. Acta Crystallogr. D 75, 861–877. https://doi.org/10.1107/
s2059798319011471.
Lin, S.C., Chung, J.Y., Lamothe, B., Rajashankar, K., Lu, M., Lo, Y.C., Lam,
A.Y., Darnay, B.G., andWu, H. (2008). Molecular basis for the unique deubiqui-
tinating activity of the NF-kappaB inhibitor A20. J. Mol. Biol. 376, 526–540.
Lu, X., Ebelle, D.L., Matsuo, H., and Walters, K.J. (2020). An Extended
Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-
Diubiquitin Structure. Structure 28, 495–506.e3.
Madeira, F., Park, Y.M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N.,
Basutkar, P., Tivey, A.R.N., Potter, S.C., Finn, R.D., and Lopez, R. (2019).
The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic
Acids Res. 47 (W1), W636–W641.
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C.,
and Read, R.J. (2007). Phaser crystallographic software. J. Appl. Cryst. 40,
658–674.
Mevissen, T.E.T., Hospenthal, M.K., Geurink, P.P., Elliott, P.R., Akutsu, M.,
Arnaudo, N., Ekkebus, R., Kulathu, Y., Wauer, T., El Oualid, F., et al. (2013).
OTU deubiquitinases reveal mechanisms of linkage specificity and enable
ubiquitin chain restriction analysis. Cell 154, 169–184.
Mevissen, T.E.T., Kulathu, Y., Mulder, M.P.C., Geurink, P.P., Maslen, S.L.,
Gersch, M., Elliott, P.R., Burke, J.E., van Tol, B.D.M., Akutsu, M., et al.
(2016). Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase
Cezanne. Nature 538, 402–405.
Murshudov, G.N., Skubák, P., Lebedev, A.A., Pannu, N.S., Steiner, R.A.,
Nicholls, R.A., Winn, M.D., Long, F., and Vagin, A.A. (2011). REFMAC5 for
the refinement of macromolecular crystal structures. Acta Crystallogr. D
Biol. Crystallogr. 67, 355–367.
Panjkovich, A., and Svergun, D.I. (2016). Deciphering conformational transi-
tions of proteins by small angle X-ray scattering and normal mode analysis.
Phys. Chem. Chem. Phys. 18, 5707–5719.
Panjkovich, A., and Svergun, D.I. (2018). CHROMIXS: automatic and interac-
tive analysis of chromatography-coupled small-angle X-ray scattering data.
Bioinformatics 34, 1944–1946.
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Materials availability
Plasmids used in this study have been deposited with and will be distributed by MRC PPU reagents and services (https://
mrcppureagents.dundee.ac.uk/). All unique/stable reagents generated in this study are available from the lead contact.
Data and code availability
d All crystallographic and small-angle scattering data have been deposited in the PDB and SASBDB, respectively, and are pub-
licly available as of the date of publication. Accession numbers are listed in the Key resources table. Original gel scans have
been deposited at Mendeley and are publicly available as of the date of publication. The DOI is listed in the Key resources table.
d This paper does not report original code
d Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.EXPERIMENTAL MODEL AND SUBJECT DETAILS
BL21(DE3) E. coli
Proteins used for biochemistry and crystallography were expressed and purified from E.coli BL21(DE3) bacteria. Competent cells
were stored at 80C until use. Cells were grown in culture at 37C with shaking until OD600 = 0.6-0.8. On induction of expression
with IPTG, cells were grown overnight at 18C with shaking.
METHOD DETAILS
Plasmids
All cDNA constructs used in this study were generated by the Cloning team of the MRC reagents and services facility, MRC Protein
Phosphorylation and Ubiquitylation Unit, University of Dundee, United Kingdom (see Table S3) and can be requested fromMRC Re-
agents and Services (https://mrcppureagents.dundee.ac.uk/).
Protein expression and purification
All recombinant GST-fusion proteins were expressed in E. coli strain BL21(DE3). The bacterial cell cultures were grown in 2xTYmedia
containing 100 mg/ml ampicillin to an OD600 of 0.6-0.8 at 37
C. Protein expression was induced with 300 mM IPTG followed by over-
night shaking at 18C. Cells were harvested at 4000 rpm for 15minutes and the pellets were resuspended in GST-Lysis Buffer (50mM
Tris-HCl pH 7.5, 300mMNaCl, 10%glycerol, 0.075%2-mercaptoethanol, 1mMbenzamidine, 1mMAEBSF, and complete protease
inhibitor cocktail (Roche)). The resuspended cells were lysed by sonication and clarified by centrifugation at 30,000 x g for 45 min ate2 Molecular Cell 81, 4176–4190.e1–e6, October 21, 2021
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OPEN ACCESSArticle4C and the lysates were incubated with Glutathione Sepharose 4B resin (Abcam) for 2 hr at 4C on a rolling shaker. Resin was
washed extensively, first with high salt buffer (25 mM Tris pH 7.5, 500 mM NaCl, and 10 mM DTT) and then with low salt buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, and 1 mM DTT). The GST tag was removed by on column cleavage with
3C protease in an overnight incubation at 4C. All purified proteins used for DUB assays or enzymes kinetics were quantified using
nanodrop at A280 and aliquots were flashed frozen in liquid nitrogen and stored at 80C. Proteins meant for ITC, SAXS or crystal-
lization were further purified by anion exchange chromatography (Resource Q, GE Healthcare Life Sciences) and eluted in a gradient
with buffer Q (50 mM Tris-HCl pH 8.5, 1 M NaCl and 2mMDTT), followed by size exclusion chromatography (Superdex 75 16/60, GE
Healthcare Life Sciences) in either: buffer I for ITC (50mMTris-HCl pH 7.5, 150mMNaCl and 250mMTCEP), buffer S for SAXS (20mM
HEPES pH 7.5, 100 mM NaCl, 5mM DTT) or buffer X for crystallization (50 mM Tris-HCl, 150 mM NaCl, 10 mM DTT). The purified
proteins were concentrated, quantified using nanodrop and flash frozen in liquid nitrogen and stored at 80C.
Deubiquitylation assays using unlabelled polyUb chains
DUBs were diluted in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT and incubated at room temperature (24C) for 10 min to fully
reduce the catalytic Cys. DUB assays were subsequently carried out where 1.9 mM of K48-Ub2 or K48-Ub3 were incubated with
1.6 mMof MINDY1 in 50 mM Tris-HCl pH 7.5, 50 mMNaCl, 10 mMDTT in a reaction volume of 10 ml. For DUB assay against different
linkage types, 1.9 mM of diUb or 2.2 mM of tetraUb of specific linkage types were incubated with 1.6 mM of MINDY1 or 1.6 mM of
MINDY2 in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT in a reaction volume of 10 mL (Figures 2H and S1B). For DUB assays
comparing activity of MINDY1FL and MINDY1cat at cleaving longer untaggedK48 chains, 3.5 mg of K48-Ub5-n or 2.2 mM of K48-Ub6
were incubated with 1.6 mM of MINDY1 in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT in a reaction volume of 10 ml. For DUB
assays comparing activity of MINDY2FL andMINDY2cat at cleaving longer untagged K48 chains, 3.5 mg of K48-Ub5-n were incubated
with 0.1 mM of MINDY2 in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT in a reaction volume of 10 ml.
For DUB assays comparing activity of MINDY2 S1, S1’, S20, S30 and S4’ site mutants and MINDY1 S20, S30 and S4’ site mutants at
cleaving pentaUb, 100 nMMINDY1/2 was incubated with 1.25 mMK48-Ub5 in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT. All
reactions were incubated at 30C and stopped at indicated time points by adding LDS buffer. The samples were separated on 4%–
12% SDS-PAGE gel (Life Technology) and silver stained using Pierce Silver stain kit (Thermo Fisher).
Generating fluorescently labeled polyUb chains
Fluorescently labeled Ub5 was synthesized as described previously (Abdul Rehman et al., 2016). Briefly, Cys-Ub 1-75 (containing a
Cys residue upstream of M1) was coupled to pre-formed Ub4. The cysteine residue of this proximal ubiquitin was then conjugated to
IRDye-800CW (Li-Cor). Fluorescently labeled longer K48-linked chains (Ubn) were synthesized using a reaction mix containing
2500 mM WT ubiquitin, 250 mM (N-term 6His)-Ub (K48R, K63C), 0.5 mM UBE1, 15 mM UBE2R1, 10 mM ATP, 50 mM Tris-HCl (pH
7.5), 10 mM MgCl2, and 0.6 mM DTT with an overnight incubation at 30C. Chains with successful incorporation of 6His-Ub
(K48R, K63C) at their distal end were separated fromWT chains using a HisTrap FF 5 mL column (Cytiva). Chains were then fraction-
ated by size over a Superdex 200 16/60 column. Fractions containing chains between Ub7-Ub20 were pooled and concentrated and
buffer exchanged into PBS. An approximate concentration was determined using the median chain length and the chains were then
reacted with a 3-fold molar excess of IRDye-800CW (Li-Cor) for 3 h at 22C (600 rpm). The reaction was quenched with 50 mM BME
and excess dye removed by desalting with a Hiprep 26/10 desalting column (Cytiva) followed by size-exclusion chromatography with
a Superdex 200 16/60 column (Cytiva).
Deubiquitylation assays using fluorescently labeled polyUb chains
Methods were the same for all fluorescent polyUb species used in this study. Both DUBs and fluorescently labeled K48-polyUb
chains were diluted in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT, and 0.25 mg/ml BSA. DUBs were activated by incubation
at room temperature for 10 min. The reaction mixtures containing 1 mM DUB and 500 nM fluorescently labeled K48-linked chains
were incubated at 30C (5 mM of MINDY1Cat/FL was used in assays with longer chains, 100 nM MINDY2 was used in the assay
comparing MINDY2 WT with ubiquitin binding site mutants). At the indicated time points, 2.5 ml of the samples was transferred to
7.5 ml LDS sample buffer to quench the reaction. The samples were resolved on 4%–12%Bist-Tris SDS gels (NuPAGE, Thermofisher)
and the gels were scanned with Odyssey CLx Imaging System at 800 nm channel and quantified with Image Studio Lite software.
Data from two independent experiments were fitted using nonlinear regression. Data fitting was performed using GraphPad Prism 8
software.
Enzyme kinetics
Steady-state kinetics of K48 linked Ub5 fluorescent chain (IR-K48-Ub5) hydrolysis by MINDY1, MINDY2 and their mutants
(Y114AMINDY1, P138AMINDY1, Y243AMINDY2 and P267AMINDY2). The catalytic domain of MINDY1 and MINDY2 and their mutants
were incubated with varying concentrations of K48 linked Ub5 fluorescent chains and the formation of K48 Ub4 at the early time
points was quantified to obtain the initial velocities. Both DUBs and fluorescently labeled K48-polyUb chains were diluted in
50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM DTT, and 0.25 mg/ml BSA. At the indicated time points (0, 3, 6, 9 and 12 minutes),
2.5 ml of the samples was transferred to 7.5 ml LDS sample buffer to quench the reaction. The SDS gels of DUB assays were scanned
with Odyssey CLx Imaging System at 800 nm channel and quantified with Image Studio Lite software. The amount of K48-Ub4Molecular Cell 81, 4176–4190.e1–e6, October 21, 2021 e3
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initial velocities obtainedwere plotted against the of K48 linked Ub5 fluorescent chains (substrate) concentration and the curves were
fitted toMichaelis-Menten equation to estimate the Kcat and Km (n = 2; mean ± SD). Data fitting was carried out usingGraphPad Prism
8 software.
ITC measurements
ITC measurements were performed onMicroCal PEAQ-ITC (Malvern) at 25C. Prior to measurements, all proteins were dialysed into
a buffer containing 50mM Tris-HCl pH 7.5, 150mM NaCl and 250mM TCEP. The syringe contained MINDY1 and was titrated into the
cell which contained K48-linked polyubiquitin chains (K48-diUb, triUb or tetraUb or pentaUb). 2 ml of MINDY1 was dispensed in 4 s
duration with 130 s spacing in between injections for a total of 16 injections. Data were analyzed and titration curves were fitted using
MicroCal PEAQ-ITC (Malvern) analysis software (n = 2; mean ± SD).
Crystallization and structure determination
MINDY1C137A:K48-Ub2
TheMINDY1-catalytic domain C137Amutant construct (residues 110-384) in 50 mM Tris-HCl pH 7.5, 150mMNaCl, and 10mMDTT
was mixed with K48-linked diUb in a 1:1 ratio and concentrated to a final concentration of 11.5 mg/ml. The crystals were grown in
hanging drop 24 well plates against the well solution of 0.1 M Tris-HCl pH 8.5, 0.2 M Lithium sulfate monohydrate and 30%PEG 400.
The crystals were flash frozen in cryo-protectant containing 0.1 M Tris-HCl pH 8.5, 0.2 M Lithium sulfate monohydrate and 35%PEG
400. Diffraction data were collected at ID23-1 beamline, ESRF, France (wavelength 0.9397 Å). The datasets were processed using
XDS (Kabsch, 2010) and then scaled using AIMLESS (Evans andMurshudov, 2013). The structure of the complexMINDY1C137A:K48-
Ub2 was solved bymolecular replacement (Phaser) (McCoy et al., 2007) usingMINDY1apo (PDB ID: 5JKN) and Ub (PDB ID: 1UBQ) as
search models. The partially built model obtained was further manually built in COOT. The complete model was obtained after iter-
ative building and refinement with COOT (Emsley et al., 2010) and REFAMC5 (Murshudov et al., 2011). The final structure was re-
refined using PDB-REDO (Joosten et al., 2014). The final data collection and refinement statistics for the MINDY1C137A:K48-Ub2
complex structure is shown in Table S4. All Figs were made using PyMOL (https://pymol.org/2/).
MINDY2C266A:K48-Ub2
The MINDY2-catalytic domain C266A mutant construct (residues 241-504) was expressed in E.coli BL21(DE3) cells as described.
Purified MINDY2 protein in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 10 mM DTT was mixed with K48-linked diUb in a 1:1 ratio
and concentrated to a final concentration of 18.0 mg/ml. The crystals grew grew in hanging drops (24 well plates) from conditions
with 0.05 M Potassium phosphate monobasic and 20% PEG 8000. The crystals were flash frozen in cryoprotectant containing
0.05 M Potassium phosphate monobasic and 5% PEG 8000 and 30% PEG 8000. Diffraction data were collected at ID29 beamline,
ESRF, France (wavelength 0.97625 Å). The datasets were processed, and structures determined as for MINDY1C137A:K48-Ub2
structure.
P138AC137A:K48-Ub2
The MINDY1 P138A C137Amutant construct (residues 110-384) was expressed in E. coli BL21(DE3) cells and purified as described.
Purified protein in 50 mM Tris-HCl pH 7.5, 150 mMNaCl, and 10 mMDTT was mixed with K48-linked diUb in a 1:1 ratio and concen-
trated to a final concentration of 14.0 mg/ml. The crystals were grown in hanging drop 24 well plates against the well solution of 0.2 M
sodiummalonate pH 7.0 and 20%PEG 3350. The crystals were flash frozen in cryo-protectant containing 0.2M sodiummalonate pH
7.0 and 35% PEG 400. Diffraction data were collected at ID30B beamline, ESRF, France (wavelength 0.99187 Å).The datasets were
processed, and structures determined as for MINDY1C137A:K48-Ub2 structure.
MINDY2apo
The catalytic domain of MINDY2 (residues 241-504) was expressed in E.coli BL21(DE3) cells and purified as described. MINDY2apo
protein in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 10 mM DTT. The crystals were grown from hanging drops containing an equal
volume of protein (12.5mg/ml) andmother liquor containing 0.1MBis Tris pH 6.0, 0.2MMgCl2 and 25%PEG 3350. The crystals were
flash frozen in cryoprotectant containing 0.1MBis Tris pH 6.0, 0.2MMgCl2 and 35%PEG 400. Diffraction datawere collected at ID29
beamline, ESRF, France (wavelength 1.07252 Å). The datasets were processed using XDS (Kabsch, 2010) and then scaled using
AIMLESS (Evans and Murshudov, 2013). The structure of the MINDY2apo was solved by molecular replacement (MoRDa) using
MINDY1apo (PDB ID: 5JKN) as search model.
MINDY1 Y114F
The catalytic domain of MINDY1 Y114F construct (residues 110-384) was expressed and purified as described. The crystals were
grown from hanging drops containing an equal volume of protein (11.5 mg/ml) and mother liquor containing 0.1 M Tris-HCl pH
8.5, 1.5 M Ammonium phosphate dibasic. The crystals were flash frozen in cryoprotectant containing 0.1 M Tris-HCl pH 8.5,
3.4 M Sodium malonate pH 8.0 and 20% glycerol. Diffraction data were collected at ID23-2 beamline, ESRF, France (wavelength
0.87313 Å). The structure of the Y114F was solved by molecular replacement (Phaser) using MINDY1apo (PDB ID: 5JKN) as search
model.
MINDY1 P138A
MINDY1 P138A (residues 110-384) was expressed and purified as described. The crystals were grown from hanging drops contain-
ing an equal volume of protein (11.05 mg/ml) and mother liquor containing 0.1 M Bis Tris Propane pH 7.0 and 0.7 M sodium citratee4 Molecular Cell 81, 4176–4190.e1–e6, October 21, 2021
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tribasic dihydrate and 30% PEG 400. Diffraction data were collected at ID23-1 beamline, ESRF, France (wavelength 0.97625 Å). The
structure of the P138A was solved by molecular replacement (Phaser) using MINDY1apo (PDB ID: 5JKN) as search model.
MINDY1 T335D
MINDY1 T335D (residues 110-384) was expressed and purified as described. The crystals were grown from hanging drops contain-
ing an equal volume of protein (12.0 mg/ml) and mother liquor containing 0.1 M HEPES-Na pH 7.5 and 0.8 M Potassium sodium
tartrate tetrahydrate. The crystals were flash frozen in cryoprotectant containing 0.07MHEPES-Na pH 7.5, 0.52MPotassium sodium
tartrate tetrahydrate and 35% glycerol. Diffraction data were collected at I03 beamline, Diamond, UK (wavelength 0.97628 Å). The
structure of the T335D was solved by molecular replacement (Phaser) using MINDY1apo (PDB ID: 5JKN) as search model.
MINDY2C266A:K48-Ub5
The catalytic domain of MINDY2C266A (residues 241-504) was expressed in E.coli BL21(DE3) cells and purified as previously
described. Purified protein in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 10 mM DTT was mixed with K48-linked Ub5 in a 1:1 ratio
and concentrated to a final concentration of 13.5 mg/ml. Crystals were grown in hanging drops containing a 2-fold excess of protein
over mother liquor containing 3% (w/v) dextran sulfate sodium salt, 0.1 M BICINE pH 8.5 and 15% (w/v) PEG 20,000. Crystals were
frozen in cryoprotectant consisting of mother liquor supplemented with 30% ethylene glycol. Diffraction data were collected at ID30-
A-1 beamline, ESRF, France. The structure was solved by molecular replacement (Phaser) using MINDY2C266A:K48-Ub2 as a search
model. The asymmetric unit contained 7 copies of the complex and clear electron density was visible for MINDY2 and the Ub mol-
ecules bound at the S1, S1’, S30 and S4’ sites. While large regions of the Ub at the S20 site are poorly represented in the electron
density, well defined electron density of the b3- and b5-strands, as well as the C terminus of this ubiquitin molecule allowed precise
positioning of this entity.
Sequence conservation
Sequences of metazoan orthologs of MINDY1 (OMAGroup 804311) andMINDY2 (OMAGroup 574560) were retrieved from the OMA
Orthology database (https://omabrowser.org/) (Altenhoff et al., 2021). The orthologous sequences of eachMINDYwere aligned using
the Clustal Omega Multiple Sequence Alignment Tool (https://www.ebi.ac.uk/Tools/msa/clustalo/) (Madeira et al., 2019). The
sequence alignments were used for surface conservation analysis with chain A of MINDY1 (PDB 6TUV) and MINDY2 (PDB 7NPI),
respectively, using the Consurf webserver (https://consurf.tau.ac.il/) (Ashkenazy et al., 2016).
Small angle X-ray scattering (SAXS)
Synchrotron radiation X-ray scattering patterns from MINDY2-apo, in complex with UbPrg, and polyubiquitin were collected at the
EMBL P12 beamline of the storage ring PETRA III (DESY, Hamburg, Germany) (Blanchet et al., 2015). Images were recorded using
a photon counting Pilatus-6Mdetector at a sample to detector distance of 3.0mand awavelength (l) of 0.12 nmcovering the range of
momentum transfer 0.01 < s < 7 nm-1 with s = 4psinq/l, where 2q is the scattering angle. To obtain data frommonodisperse samples
(MINDY2-apo, MINDY2Ub, MINDY2-Ub2, MINDY2-Ub3, MINDY2-Ub4 and MINDY2-Ub5), samples were passed through size
exclusion chromatography (Superdex 200 10/300) directly coupled to the SAXS instrument (SEC-SAXS). Only frames corresponding
to the main elution peaks were considered. The SAXS data collected from the buffer components before the elution peak was used
for background subtraction. The overall structural parameters of the apo construct derived from the SAXS data are compatible with a
monomeric species while those for the complexes show trends typical of complex formation and thus confirm the binding of the
increasing number of ubiquitin molecules to MINDY2 (Table S2).
One second sample exposures were recorded throughout the entire chromatography step. Buffer S (20 mM HEPES pH 7.5,
100mMNaCl, 5mMDTT) was used asmobile phase. 100 ml of purified sample were injected onto a Superdex 200 10/300 (GEHealth-
care) column and the flow rate was set to 0.5 ml/min. SAXS data were also recorded frommacromolecule-free fractions correspond-
ing to the matched solvent blank. Data reduction to produce final scattering profiles of MINDY 2 constructs was performed using
standard methods. Briefly, 2D-to-1D radial averaging was performed by the SASFLOW pipeline (Franke et al., 2017) CHROMIXS
was used for visualization and reduction of the SEC-SAXS datasets (Panjkovich and Svergun, 2018). Aided by the integrated predic-
tion algorithms in CHROMIXS the optimal frames within the elution peak and the buffer regions were selected. Single buffer frames
were then subtracted from sample frames one by one, scaled and averaged to produce the final subtracted curve. The radius of gy-
ration RG was computed for each construct by Guinier approximation (Guinier, 1939). The molecular mass (MM) of the solutes was
evaluated based on the concentration independent approach using Porod invariant (Porod, 1951) as implemented in the ATSAS
package (Hajizadeh et al., 2018). The indirect Fourier transform of the SAXS data and the corresponding probable real space pair
distance distribution (p(r) versus r profile) of the MINDY2 constructs were calculated using GNOM (Svergun, 1992) yielding also
the particle diameter Dmax. The theoretical curves were calculated from the atomic models with CRYSOL (Svergun et al., 1995). In
case of systematic deviations, normal mode analysis as implemented in SREFLEX (Panjkovich and Svergun, 2016) was employed
to refine the crystallographic models. Possibilities of having mixtures of complexes with distinguishable Ub2 binding positions
were analyzed with OLIGOMER (Konarev et al., 2003).The SAXS data (as summarized in Table S2) as well as fits to the curves
computed from the crystal structures and from the refined models have been deposited into the Small-Angle Scattering Biological
Data Bank (SASBDB) (Valentini et al., 2015).Molecular Cell 81, 4176–4190.e1–e6, October 21, 2021 e5
ll
OPEN ACCESS ArticleQUANTIFICATION AND STATISTICAL ANALYSIS
All gels using fluorescent chains were repeated such that n = 3. Intensities were quantified using ImageStudioLite (Li-Cor). Intensities
were input into GraphPad Prism 8.2.1 from which SD/SEMwere derived and graphs plotted. All kinetic parameters were determined
as described and DUB assays quantified using GraphPad Prism 8.2.1 software. ITC data were analyzed and titration curves were
fitted using MicroCal PEAQ-ITC (Malvern) analysis software (n = 2; mean ± SD).e6 Molecular Cell 81, 4176–4190.e1–e6, October 21, 2021
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Figure S1 Crystal structure of MINDY1/2 in complex with K48-linked diUb 
A) Secondary structure alignment of MINDY1 and MINDY2 based on their crystal structures 
using ESPRIPT webserver (http://espript.ibcp.fr/ESPript/ESPript/ ). The secondary structure 
elements of MINDY1 and MINDY2 are shown in pale cyan and light orange respectively.    
B) Silver stained gels of DUB assays testing activity and specificity of polyUb cleavage by MINDY2 
catalytic domain (241–504). 1.6 µM of DUB was incubated with 2.2 µM of tetraUb chains for the 
indicated time points. 
C) Superposition of the crystal structures of the minimal catalytic domains of MINDY1 (pale-
cyan) and MINDY2 (light-orange) shown in cartoon representation.  
D) The MINDY2C266A:K48-diUb complex crystal structure is shown with MINDY2 in cartoon (blue 
white). Ub molecules are depicted with transparent surfaces (tv-orange:Ubprox and yelloworange: 
Ubdist). I44 patches on Ub are coloured blue and an alternate view of the bound diUb rotated by 
220º along the x-axis is shown on the right side. Schematic representation of MINDY2C266A:K48-
diUb complex (inset). 
E) The crystal structure of MINDY1C137A:K48-diUb complex with electron density for both proximal 
and distal Ub (orange and light-brown) contoured at 1.0 σ. In the inset, the Fo − Fc omit electron 
density map was generated from coefficients calculated by removing G76 and K48 from the distal 
and proximal Ub moieties, respectively, from the atomic model for 10 cycles of refinement. The 
Fo−Fc map is contoured at 3.0 s  whereas 2Fo−Fc map is contoured at 1.0 s. 
F) As in (E) for the MINDY2C266A:K48-diUb complex. 
G) DUB assay monitoring cleavage of K48-Ub5 by MINDY2cat and the indicated S1 and S1’ 
mutants. 




Figure S2 Analysis of K48-Ub2 interaction with MINDY1 
A) Superposition of the MINDY1C137A:K48-Ub2 complex with MINDY1~UbPrg complex reveals that 
proximal Ub stabilises the binding of Ub onto the S1 site. 
B-C) The evolutionary conservation score of MINDY1 was calculated using the crystal structure of 
MINDY1 and primary sequences from 19 species using the ConSurf webserver. The conservation 
score was projected both on to the primary sequence (A) and the surface representation of the 
crystal structure of MINDY1 (panel B) The distal and proximal Ub binding region has been 
highlighted. In the inset, a close-up view reveals conservation of the active site and the catalytic 
groove (cyan dashed box) accommodating the scissile bond across the active site.  
D) Surface representation of MINDY1 highlighting key interaction interfaces.   
E) Close-up view of the critical polar interaction between MINDY1 (pink) and the proximal Ub 
(orange).  
F) DUB assay comparing activity of different S1’ site mutants at cleaving fluorescently-labelled 
pentaUb. The percent hydrolysis of K48 linked polyUb chains for the different mutants is plotted 
against time for the DUB assay (bottom). 
G) Comparison of different K48-linked diUb structures shown in surface representation with the 
I44 patches highlighted in blue. MINDY1C137A:K48-diUb (PDB ID: 6TUV); Solution structure of the 
Rpn1 T1 site with K48-linked diUb in the contracted binding mode (PDB ID: 2N3W)  and in the 
extended binding mode (PDB ID: 2N3V) (Chen et al., 2016); A new crystal form of K48-linked diUb 
(PDB ID: 3M3J) (Trempe et al., 2010); Crystal structure of an open conformation of K48-linked 
diUb at pH 7.5 (PDB ID: 3NS8) ; Crystal structure of diUb bound to SARS PLpro (PDBID: 5E6J) 
(Békés et al., 2016b); hRpn13:hRpn2:K48-diUb structure (PDB ID: 6UYJ) (Lu et al., 2020) and 
crystal structure of a diUb and model for interaction with E2 (PDBID:1AAR) (Cook et al., 1992b).  
H) Comparison of the conformation adopted by the Ub molecules present in the 
OTUB1~Ub:Ubc13~Ub complex (PDB ID: 4LDT) superposed on the distal Ub of 
MINDY1C137A:K48-diUb (PDB ID: 6TUV) 





Figure S3 Cys loop regulates activity of MINDY1 and MINDY2 
A) Cartoon representation of the crystal structures of MINDY1(apo) and the MINDY1C137A:K48-
Ub2 complexes (RMSD 1.0 Å). Close up view of the Cys loop in the apo state (cyan) and active 
state (pink). 
B) The hydrogen bond network of the Cys loop of MINDY1(apo). Dashed lines indicate hydrogen 
bonds. 
C) Hydrogen bonds formed by the backbone of P138 in MINDY1 (apo). 
D) Close up views of hydrophobic interactions (left) and hydrogen bonding with P136 and P138 
(right) in the MINDY1C137A:K48-Ub2 complex.  
E) Interaction network of the Cys loop in MINDY2 apo.  
F) Superposition of the Cys loop in MINDY2apo (cyan) and MINDY2C266A:K48-Ub2 complex (pink). 
The incoming isopeptide can be seen clashing with the Cys loop in MINDY2 apo. 
G) Close-up view showing electron density 2Fo-Fc map contoured at 1.0 s of the isopeptide bond 
of the K48-Ub2 from the P138A:K48-Ub2 complex. 
H) Superposition of MINDY1C137A:K48-Ub2 and MINDY1C137A P138A:K48-Ub2 complexes. 
I) Close-up view of the MINDY1C137A P138A:K48-Ub2 complex showing the hydrogen bonding 
network of the mutant Cys loop. 
J-K) Omit maps for MINDY1apo and MINDY1 P138A Cys loops. The |Fo|−|Fc| electron density map 
was generated from coefficients calculated by deleting the Cys loop residues from the respective 
atomic models for 10 cycles of refinement. The Fo−Fc map is contoured at 3.0 s and the 2Fo−Fc 
map is contoured at 1.0 s. 
L) DUB assay monitoring K48-Ub3 chain hydrolysis by MINDY2 WT and the mutants P265A, 
P267A and the double mutant P265A P267A. These two prolines flank the catalytic cysteine 
(C266). 
M) Steady-state enzyme kinetics of K48-linked pentaUb cleavage by MINDY2 WT and the P267A 
mutant. The DUB was incubated with varying concentrations of fluorescently labelled pentaUb. (n= 
2; mean ± SD). 




Figure S4 Autoinhibition and activation of MINDY1 and MINDY2 
A) Close up view of Y114 in a superposition between MINDY1 (apo) and MINDY1~UbPrg. Dotted 
lines indicate hydrogen bond. 
B) Close up view of superposition of MINDY2 apo and MINDY2C266A:K48-Ub2 complex showing 
Y243. A292, the equivalent residue of S163 in MINDY2 does not induce lateral movement of the 
tyrosine observed in MINDY1. Asterisk indicates residues in complex.  
C) Steady-state enzyme kinetics of K48-linked pentaUb cleavage by MINDY2 Y243F mutant. (n=1) 
D) DUB assay monitoring the cleavage of K48linked-triUb chain by MINDY1 WT and Y114A and 
Y114F mutants. Of note, expression and stability of MINDY1 is affected by the Y114A mutation 
suggesting an additional structural role for Y114 in stabilizing local structure especially around 
the Cys loop. 
E) A close-up view of MINDY1 apo catalytic site. The catalytic cysteine (C137) is rotated away 
from hydrogen bonding distance with the catalytic histidine (H319). Dotted lines indicate hydrogen 
bond.  
F) A close-up view of the catalytic site in the MINDY1C137A:K48-Ub2 complex. The isopeptide bond 
can be seen interacting with the catalytic H319. Q131 is seen interacting with the isopeptide bond. 
Dotted lines indicate hydrogen bond.  
G) A close-up view of the catalytic site in the MINDY1~UbPrg complex, where both H319 and 
Q131 exist in two alternate conformations. Dotted lines indicate hydrogen bond.  
H) A close-up view of the catalytic site in MINDY2 showing key residues. The catalytic cysteine 
(C266) in MINDY2 is out of plane with the other catalytic residues and instead can be seen 
interacting with the non-catalytic Y243. Unlike MINDY1, the oxyanion forming glutamine (Q260) is 
not able to form any bonds with the flipped out catalytic histidine (H448). Dashed lines indicate 
hydrogen bond. 
I) A close-up view of MINDY2 (apo) showing the catalytic cysteine (C266) rotated away from the 
hydrogen bonding distance with the catalytic histidine (H448).  
J) View of the catalytic site in the MINDY2C266A:K48-Ub2 complex showing catalytically productive 
rearrangements upon K48-diUb binding. The catalytic histidine (H448) is seen to have flipped in 
plane with the catalytic cysteine (C266*). The oxyanion forming glutamine (Q260) is seen 
interacting with the isopeptide bond of the bound K48 chain. 






Figure S5 Catalytic mechanism of MINDY2 
A) Close up view of the catalytic site in the crystal structure of MINDY1C137A:K48-Ub2 showing the 
coordination of a water molecule by T335 and H319.  The respective residues are shown with 2Fo-
Fc electron density contoured at 1.0 s. 
B)  Close up view of the catalytic site in the crystal structure of MINDY1 T335D showing the 
formation of an ionic bond between T335D and the catalytic histidine (H319). The respective 
residues are shown with 2Fo-Fc electron density contoured at 1.0 s. 
C)- D) Close up view of the catalytic site architecture in inhibited state MINDY2 apo (B) and in the 
active state in MINDY2C266A:K48-Ub2 (C). 
E) DUB assay monitoring cleavage of fluorescently labelled K48-linked pentaUb chains by 
MINDY2 and the indicated mutants. Quantification of pentaUb cleavage is shown on the right. Gel 
is truncated to exclude mutants irrelevant to the study. 
Related to Figure 4  
 
 
Figure S6 Recognition of K48 chains by MINDY1/2 
A-B) MINDY1 and MINDY2 prefer to cleave longer chains. The percentage of fluorescently labelled 
K48-linked Ub2, Ub3, and Ub5 cleaved over time by MINDY1 and MINDY2 is plotted. n=2; 
mean±SD 
C) Isothermal titratison calorimetry (ITC) data measuring binding of MINDY1C137A with K48-linked 
polyUb chains of the indicated lengths. Indicated concentrations of MINDY in the syringe was 
injected into polyUb chains in the cell. n=2; mean±SD 
D) ITC data measuring binding of MINDY1C137A to K29- and K33-linked tetraUb. Indicated 
concentrations of MINDY in the syringe was injected into tetraUb chains in the cell. 
E) Consurf analysis of the Ub binding sites on MINDY1 
F) DUB assay of a series of mutations at the S4’ site of MINDY2 against K48-Ub4 
G) DUB assay comparing cleavage of K48-Ub5 by WT MINDY1cat and S2’, S3’ and S4’ site 
mutants. 






Figure S7. Small angle X-ray scattering analysis of MINDY2 complexes 
A) The models used in the curve fitting with the SAXS data are depicted along with a schematic 
representation.  
B) MINDY2C266A:K48-Ub2 model validated with considerable agreement. 
C) MINDY2C266A:K48-Ub3 models observed and validated in SAXS measurements with some 
deviations and improved curve fitting post normal mode analysis run.  The model was obtained by 
refinement of Ub positions. 
D) MINDY2C266A:K48-Ub4 models were corrected after normal mode analysis and validated with 
considerable agreement. 
E) MINDY2C266A:K48-Ub5 models validated with considerable agreement. 




Figure S8 Mechanism of substrate recognition and cleavage by MINDY1/2 
A) Crystal structure of MINDY2C266A:K48-Ub5 complex highlighting the solvent-exposed Lys48 
residue of Ubdist.  
B) Related to Fig 7, this shows the structures and the transitions in the catalytic cycle of MINDY1 
going from inactive state to substrate bound active state and MINDY1 in the transition state 
bound to product intermediate. 
Related to Figure 7 
 
Table S1: Summary of major Ub interactions with DUBs, related to Figure 1 
Colour coding: Hydrophobic; Hydrogen bond; Ionic bond; Cation-Pi 
PDB ID Title of Structure Ubprox Ubdist 
6TUV, 6Z7V MINDY1 in complex with 
K48-linked diubiquitin 
L 8, I44 
V70, F45 
R42 
L 8, I44 
V70, L73 
R42 
6NJD Crystal structure of RavD 
from Legionella pneumophila 






L8, I44, V70, L73, 
L73, R74 
K6, R42, K48, R72 
5LRV Structure of 
Cezanne/OTUD7B OTU 





I44, I36, L71, L73, 
Ile13, I30 
L69, L8, R42, R72, 
R74 
2ZNV Crystal structure of human 
AMSH-LP DUB domain in 





L73, V70, I44, L8, 
I36, L71 
R42, R72, R74, K48, 
K6, His68 
D39, R74 
4NQL The crystal structure of the 
DUB domain of AMSH 
orthologue, Sst2 from S. 
pombe, in complex with 









Crystal structure of USP30 





L71, L73, I36, Pro37, 
F4, G76 
G75, R74, R42, R72, 
K48, K6 
E16, F4, K6 
3WXE Crystal structure of CYLD 
USP domain (C596S) in 













3WXG Crystal structure of CYLD 
USP domain (C596A) in 
complex with K63-linked 
diubiquitin 
F4, E64, K63, Glu18 
K29, K6, E16 
V70, L8, I36, L69, 
L71, L73 






Crystal structure of OTULIN 
OTU domain (C129A) in 
complex with M1- di ubiquitin 
Structure of OTULIN bound 
to the M1-linked diubiquitin 
activity probe 
Gumby/Fam105B in complex 












Table S2: SAXS data collection, related to Figure 5  
Data collection parameters
Radiation source PETRA III 
(DESY, Hamburg, Germany) 
Beamline EMBL P12
Detector PILATUS 6M
Beam geometry (mm, FWHM) 0.12 x 0.20
Wavelength (nm) 0.12 
Sample-detector distance (m) 3.0
Momentum transfer s range (nm-
1)
0.01 – 7.0
Exposure time (s) 1 s (SEC-SAXS mode)
Temperature (°C) 20
Buffer 20 mM Hepes, 100 mM NaCl, 5 mM DTT, pH 7.5



















Number of ubiquitins 0 1 2 3 4 5
Concentration (mg/ml) 8.8 10.5 9.9 12.2 13.7 17.1
Rg from Guinier approximation 
(nm)
2.1±0.1 2.3±0.1 2.5±0.1 2.8±0.2 2.9±0.2 2.8±0.2
Dmax (nm) 6.5±0.3 6.8±0.3 8.0±0.4 8.8±0.5 9.2±0.5 9.0±0.6
Excluded (Porod) volume (nm3) 45±4 58±6 68±7 97±9 111±10 116±10
Molecular weight from
Porod invariant, (kDa)
28±3 35±4 43±5 60±6 69±7 73±7
Molecular weight from
sequence (kDa)
31.0 39.5 48.0 56.5 65.0 73.5
Data analysis and modelling
Primary data reduction SASFLOW 
Data processing PRIMUS/CHROMIXS
Calculation of theoretical data CRYSOL 
χ2 Crysol 2.04 1.47 5.23 2.07 3.75 1.48
Model refinement SREFLEX
χ2 SREFLEX 1.49 - - 1.15 1.32 -
RMSD 3.91 - - 5.01 3.35 -
Multicomponent Mixture Analysis OLIGOMER
χ2 OLIGOMER - - 1.90 - - -












Table S3: Details of cDNA constructs used in study, related to Figures 1-6 
Protein Expressed protein Tag Cleaved Vector type Plasmid 
DU 
number 
MINDY1FL GST-MINDY1 1-469 Yes Bacterial pGEX6P1 49563 
MINDY2FL GST-MINDY2 1-621 Yes Bacterial pGEX6P1 46765 
MINDY1cat GST-MINDY1 110-384 Yes Bacterial pGEX6P1 47257 








241-504 Yes Bacterial pGEX6P1 55471 
I266A GST-MINDY1-I266A 110-384 Yes Bacterial pGEX6P1 47820 
F339A GST-MINDY1-F339A 110-384 Yes Bacterial pGEX6P1 47665 
I266A-F339A GST-MINDY1-I266A F339A 110-384 Yes Bacterial pGEX6P1 67842 
I395A GST-MINDY2 I395A 241-504 Yes Bacterial pGEX6P1 55941 
F468A GST-MINDY2 F468A 241-504 Yes Bacterial pGEX6P1 55878 
R316A GST-MINDY1-R316A 110-384 Yes Bacterial pGEX6P1 47668 
N317A GST-MINDY1-N317A 110-384 Yes Bacterial pGEX6P1 59172 
D336A GST-MINDY1-D336A 110-384 Yes Bacterial pGEX6P1 47667 
P138A GST-MINDY1-P138A 110-384 Yes Bacterial pGEX6P1 47661 
P138G GST-MINDY1-P138G 110-384 Yes Bacterial pGEX6P1 59586 
P138L GST-MINDY1-P138L 110-384 Yes Bacterial pGEX6P1 59683 
P138W GST-MINDY1-P138W 110-384 Yes Bacterial pGEX6P1 59684 
P136A GST-MINDY1-P136A 110-384 Yes Bacterial pGEX6P1 47821 
P136A P138A GST-MINDY1-P136A P138A 110-384 Yes Bacterial pGEX6P1 47815 
Y114A GST-MINDY1-Y114A 110-384 Yes Bacterial pGEX6P1 47659 
Y114F GST-MINDY1-Y114F 110-384 Yes Bacterial pGEX6P1 47671 
N134A GST-MINDY1-N134A 110-384 Yes Bacterial pGEX6P1 59152 
S321A GST-MINDY1-S321A 110-384 Yes Bacterial pGEX6P1 47670 
S321D GST-MINDY1-S321D 110-384 Yes Bacterial pGEX6P1 59666 
T335V GST-MINDY1-T335V 110-384 Yes Bacterial pGEX6P1 47757 
T335D GST-MINDY1-T335D 110-384 Yes Bacterial pGEX6P1 58884 
P265A GST-MINDY2 P265A 241-504 Yes Bacterial pGEX6P1 59611 
P267A GST-MINDY2 P267A 241-504 Yes Bacterial pGEX6P1 55477 
P265A P267A GST-MINDY2 P265A P267A 241-504 Yes Bacterial pGEX6P1 59610 
P138A C137A GST-MINDY1C137A P138A 110-384 Yes Bacterial pGEX6P1 55726 
S450A GST-MINDY2-S450A 241-504 Yes Bacterial pGEX6P1 55826 
T464V GST-MINDY2-T464V 241-504 Yes Bacterial pGEX6P1 55825 
V242G I289A GST-MINDY2 V242G I289A 241-504 Yes Bacterial pGEX6P1 70504 
V242S I289A GST-MINDY2 V242S I289A 241-504 Yes Bacterial pGEX6P1 70505 
L304A GST-MINDY2 L304A 241-504 Yes Bacterial pGEX6P1 70501 






Yes Bacterial pGEX6P1 70512 
R342E GST-MINDY2 R342E 241-504 Yes Bacterial pGEX6P1 70502 
E350A GST-MINDY2 E350A 241-504 Yes Bacterial pGEX6P1 55811 






Yes Bacterial pGEX6P1 70510 
Ubiquitin K48R, 
K63C 
6His-Ub K48R K63C 
2-76 Yes Bacterial pET15b 70511 
Ubiquitin 1-76 Ubiquitin (expressed tagless) Tagless Bacterial pET24 20027 
Ubiquitin 1-75 Ub-Intein-CBD 1-75 Yes Bacterial pTXB1 24149 
